Related Experiment Video
Updated: May 14, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNA aberrances in head and neck cancer: pathogenetic and clinical significance
Hsi-Feng Tu1, Shu-Chun Lin, Kuo-Wei Chang
1Department of Dentistry, National Yang-Ming University Hospital, Yi-Lan, Taiwan.
Purpose Of Review:
MicroRNAs (miRNAs) play crucial roles in modulating the neoplastic process of cancers including head and neck squamous cell carcinoma (HNSCC). miRNAs modulate pathogenesis by inhibiting target genes. Understanding how aberrant miRNAs are involved in HNSCC pathogenesis should help to validate potential clinical applications that target these entities.
Recent Findings:
miR-21, miR-31, miR-504 and miR-10b are important oncogenic miRNAs that are involved in HNSCC and target tumour suppressor genes. The tumour suppressor roles of the let-7 family, the miR-99 family, miR-107, miR-133a, miR-137, miR-138 and miR-375 with respect to their targeting of oncogenes are unequivocal and have been confirmed by many studies. In addition, miR-21, let-7, miR-107, miR-138 and miR-200c seem to play complicated roles in regulating stemness or the epithelial-mesenchymal transition of tumour cells. The clinical implications of these tumour-associated miRNAs are generally in agreement with their functional roles.
Summary:
A number of pathways that become disregulated by aberrant miRNAs have been identified specifically for HNSCC. Analysis of these networks and their therapeutic interception might facilitate the prediction of disease status and help with the design of therapeutic trials.
Insights
MicroRNAs (miRNAs) are key regulators in head and neck squamous cell carcinoma (HNSCC) development. Understanding their roles in HNSCC pathogenesis can lead to new therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are critical regulators of gene expression involved in cancer development.
- Aberrant miRNA expression is implicated in the pathogenesis of various cancers, including head and neck squamous cell carcinoma (HNSCC).
Purpose of the Study:
- To review the roles of specific miRNAs in HNSCC pathogenesis.
- To understand how dysregulated miRNAs contribute to HNSCC development and progression.
- To explore the potential clinical applications of targeting miRNAs in HNSCC.
Main Methods:
- Literature review of studies investigating miRNA function in HNSCC.
- Analysis of miRNA targeting of oncogenes and tumor suppressor genes.
- Examination of the clinical implications of tumor-associated miRNAs.
Main Results:
- Oncogenic miRNAs (e.g., miR-21, miR-31) promote HNSCC by targeting tumor suppressor genes.
- Tumor suppressor miRNAs (e.g., let-7 family, miR-99 family) inhibit HNSCC by targeting oncogenes.
- Certain miRNAs (e.g., miR-21, let-7) exhibit complex roles in regulating cancer stemness and epithelial-mesenchymal transition.
Conclusions:
- Dysregulated miRNA pathways are identified in HNSCC.
- Analysis of miRNA networks and therapeutic targeting may aid in disease prediction and clinical trial design.
Related Concept Videos
Abnormal Proliferation
MicroRNAs
MicroRNAs
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
Mechanisms of Retrovirus-induced Cancers

